Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc.verified

FULC

Price:

$3.26

Market Cap:

$203.43M

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy; and FTX-6058, an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. The company is also discovering drug targets for the treatments of rare neuromuscular, muscular, central nervous system, and hematologic disorders, as well as cardiomyopathies and pulmon...[Read more]

Industry

Biotechnology

IPO Date

2019-07-18

Stock Exchange

NASDAQ

Ticker

FULC

The Enterprise Value as of November 2024 (TTM) for Fulcrum Therapeutics, Inc. (FULC) is 126.38M

According to Fulcrum Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 126.38M. This represents a change of -66.78% compared to the average of 380.38M of the last 4 quarters.

Fulcrum Therapeutics, Inc. (FULC) Historical Enterprise Value (quarterly & annually)

How has FULC Enterprise Value performed in the past?

The mean historical Enterprise Value of Fulcrum Therapeutics, Inc. over the last ten years is 280.01M. The current 126.38M Enterprise Value has changed 4.41% with respect to the historical average. Over the past ten years (40 quarters), FULC's Enterprise Value was at its highest in in the September 2021 quarter at 967.18M. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

280.01M

Median

239.86M

Minimum

87.14M

Maximum

590.12M

Fulcrum Therapeutics, Inc. (FULC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Fulcrum Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 175.25%

Maximum Annual Enterprise Value = 590.12M

Minimum Annual Increase = -48.17%

Minimum Annual Enterprise Value = 87.14M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023399.10M30.48%
2022305.86M-48.17%
2021590.12M146.03%
2020239.86M175.25%
201987.14M-44.12%
2018155.94M-14.33%

Fulcrum Therapeutics, Inc. (FULC) Average Enterprise Value

How has FULC Enterprise Value performed in the past?

The current Enterprise Value of Fulcrum Therapeutics, Inc. (FULC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

431.69M

5-year avg

324.42M

10-year avg

280.01M

Fulcrum Therapeutics, Inc. (FULC) Enterprise Value vs. Peers

How is FULC’s Enterprise Value compared to its peers?

Fulcrum Therapeutics, Inc.’s Enterprise Value is greater than RAPT Therapeutics, Inc. (47.88M), less than Mirum Pharmaceuticals, Inc. (2.01B), greater than BeyondSpring Inc. (77.93M), less than Stoke Therapeutics, Inc. (501.96M), less than Phathom Pharmaceuticals, Inc. (1.52B),

Build a custom stock screener for Fulcrum Therapeutics, Inc. (FULC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fulcrum Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Fulcrum Therapeutics, Inc. (FULC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Fulcrum Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Fulcrum Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Fulcrum Therapeutics, Inc. (FULC)?

What is the 3-year average Enterprise Value for Fulcrum Therapeutics, Inc. (FULC)?

What is the 5-year average Enterprise Value for Fulcrum Therapeutics, Inc. (FULC)?

How does the current Enterprise Value for Fulcrum Therapeutics, Inc. (FULC) compare to its historical average?